Pharmahungary Group is offering a unique service in preclinical development, i.e. small and large animal multicenter studies for myocardial infarction and heart failure. The know-how and network of the sites were developed in a COST (EU-CARDIOPROTECTION, CA16225) and COST Innovators Grant (IMPACT, IG16225) led by Semmelweis University and University College London. Pharmahungary, the SME partner will utilize the know-how of preclinical multicenter trials according to the agreement with the consortium.
See selected references: